Press Releases
 
Press Releases
  Date Title and Summary View
Mar 30, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ:EXAS) today announced that Tufts Health Plan, with more than 1 million members across Massachusetts and Rhode Island, will cover Cologuard as a colon cancer screening test effective March 15, 2015. Cologuard is the fir...
Mar 13, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that, in support of the Company's continued growth plans, it has issued restricted stock units covering a total of 125,661 shares of common stock to 166 new non-executive employees under its previously announced inducement grant ...
Mar 11, 2015
First and only FDA-approved noninvasive stool DNA screening test for colorectal cancer MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced Wheaton Franciscan Healthcare is the first healthcare system in Milwaukee to offer Cologuard®, the first a...
Mar 9, 2015
MADISON, Wis., & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today an agreement to co-promote Exact Sciences' Cologuard®, the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer...
Mar 4, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ:EXAS) today announced that Aetna, one of the country's leading health plans, will cover Cologuard under its Medicare Advantage plan, reaching 967,000 members across the country. The three year agreement will go into effect on April 1, 2015. ...
Feb 27, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that, in support of the Company's continued growth plans, the Compensation Committee of the Company's Board of Directors has approved the reservation of 315,000 shares of common stock to be used exclusively for the grant of equit...
Feb 25, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in the Cowen and Company 35th Annual Health Care Conference in Boston. Kevin T. Conroy, the company's chairman and chief executive, will make Exact Science's presentation...
Feb 24, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the quarter and year ended Dec. 31, 2014. Exact reported total revenues of $1.5 million for the fourth quarter of 2014 compared to total revenues of $1.0 million during the same period ...
Feb 23, 2015
Agreement Offers Up to $9 Million in Performance-Based Incentives to Create More than 750 Jobs, Invest $26 Million in Wisconsin MADISON, Wis.--(BUSINESS WIRE)-- The Wisconsin Economic Development Corporation (WEDC) announced today that it will provide tax credits of up to $9 million to Exact...
Feb 20, 2015
Exact Sciences: WHAT:   Exact Sciences Chairman and CEO Kevin Conroy and Lieutenant Governor Rebecca Kleefisch will make a major announcement about the cancer diagnostic...
Page:
1
... NextLast
= add release to Briefcase